These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28069485)

  • 1. Alternative approaches for identifying acute systemic toxicity: Moving from research to regulatory testing.
    Hamm J; Sullivan K; Clippinger AJ; Strickland J; Bell S; Bhhatarai B; Blaauboer B; Casey W; Dorman D; Forsby A; Garcia-Reyero N; Gehen S; Graepel R; Hotchkiss J; Lowit A; Matheson J; Reaves E; Scarano L; Sprankle C; Tunkel J; Wilson D; Xia M; Zhu H; Allen D
    Toxicol In Vitro; 2017 Jun; 41():245-259. PubMed ID: 28069485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative approaches for acute inhalation toxicity testing to address global regulatory and non-regulatory data requirements: An international workshop report.
    Clippinger AJ; Allen D; Jarabek AM; Corvaro M; Gaça M; Gehen S; Hotchkiss JA; Patlewicz G; Melbourne J; Hinderliter P; Yoon M; Huh D; Lowit A; Buckley B; Bartels M; BéruBé K; Wilson DM; Indans I; Vinken M
    Toxicol In Vitro; 2018 Apr; 48():53-70. PubMed ID: 29277654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reflections on the progress towards non-animal methods for acute toxicity testing of chemicals.
    Prior H; Casey W; Kimber I; Whelan M; Sewell F
    Regul Toxicol Pharmacol; 2019 Mar; 102():30-33. PubMed ID: 30578838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge sharing to facilitate regulatory decision-making in regard to alternatives to animal testing: Report of an EPAA workshop.
    Ramirez T; Beken S; Chlebus M; Ellis G; Griesinger C; De Jonghe S; Manou I; Mehling A; Reisinger K; Rossi LH; van Benthem J; van der Laan JW; Weissenhorn R; Sauer UG
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):210-26. PubMed ID: 26188116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status of acute systemic toxicity testing requirements and data uses by U.S. regulatory agencies.
    Strickland J; Clippinger AJ; Brown J; Allen D; Jacobs A; Matheson J; Lowit A; Reinke EN; Johnson MS; Quinn MJ; Mattie D; Fitzpatrick SC; Ahir S; Kleinstreuer N; Casey W
    Regul Toxicol Pharmacol; 2018 Apr; 94():183-196. PubMed ID: 29408321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute toxicity testing of chemicals-Opportunities to avoid redundant testing and use alternative approaches.
    Creton S; Dewhurst IC; Earl LK; Gehen SC; Guest RL; Hotchkiss JA; Indans I; Woolhiser MR; Billington R
    Crit Rev Toxicol; 2010 Jan; 40(1):50-83. PubMed ID: 20144136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fish embryo toxicity test as an animal alternative method in hazard and risk assessment and scientific research.
    Embry MR; Belanger SE; Braunbeck TA; Galay-Burgos M; Halder M; Hinton DE; Léonard MA; Lillicrap A; Norberg-King T; Whale G
    Aquat Toxicol; 2010 Apr; 97(2):79-87. PubMed ID: 20061034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Models for Acute Oral Systemic Toxicity: A Workshop to Bridge the Gap from Research to Regulation.
    Kleinstreuer NC; Karmaus A; Mansouri K; Allen DG; Fitzpatrick JM; Patlewicz G
    Comput Toxicol; 2018 Nov; 8(11):21-24. PubMed ID: 30320239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Acute Oral Systemic Toxicity Using a Multifingerprint Similarity Approach.
    Alberga D; Trisciuzzi D; Mansouri K; Mangiatordi GF; Nicolotti O
    Toxicol Sci; 2019 Feb; 167(2):484-495. PubMed ID: 30371864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Third FRAME Toxicity Committee: working toward greater implementation of alternatives in toxicity testing.
    Combes RD; Balls M; Bansil L; Barratt M; Bell D; Botham P; Broadhead C; Clothier R; George E; Fentem J; Jackson M; Indans I; Loizou G; Navaratnam V; Pentreath V; Phillips B; Stemplewski H; Stewart J
    Altern Lab Anim; 2004 Jun; 32 Suppl 1B():635-42. PubMed ID: 23581152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report from the EPAA workshop: in vitro ADME in safety testing used by EPAA industry sectors.
    Schroeder K; Bremm KD; Alépée N; Bessems JG; Blaauboer B; Boehn SN; Burek C; Coecke S; Gombau L; Hewitt NJ; Heylings J; Huwyler J; Jaeger M; Jagelavicius M; Jarrett N; Ketelslegers H; Kocina I; Koester J; Kreysa J; Note R; Poth A; Radtke M; Rogiers V; Scheel J; Schulz T; Steinkellner H; Toeroek M; Whelan M; Winkler P; Diembeck W
    Toxicol In Vitro; 2011 Apr; 25(3):589-604. PubMed ID: 21167275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automation of an in vitro cytotoxicity assay used to estimate starting doses in acute oral systemic toxicity tests.
    Bouhifd M; Bories G; Casado J; Coecke S; Norlén H; Parissis N; Rodrigues RM; Whelan MP
    Food Chem Toxicol; 2012 Jun; 50(6):2084-96. PubMed ID: 22465836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The integrated acute systemic toxicity project (ACuteTox) for the optimisation and validation of alternative in vitro tests.
    Clemedson C; Kolman A; Forsby A
    Altern Lab Anim; 2007 Mar; 35(1):33-8. PubMed ID: 17411349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Workshop on the validation and regulatory acceptance of innovative 3R approaches in regulatory toxicology - Evolution versus revolution.
    Burgdorf T; Piersma AH; Landsiedel R; Clewell R; Kleinstreuer N; Oelgeschläger M; Desprez B; Kienhuis A; Bos P; de Vries R; de Wit L; Seidle T; Scheel J; Schönfelder G; van Benthem J; Vinggaard AM; Eskes C; Ezendam J
    Toxicol In Vitro; 2019 Sep; 59():1-11. PubMed ID: 30946968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for acute systemic toxicity testing.
    Stitzel KA; Spielmann H; Griffin G
    ILAR J; 2002; 43 Suppl():S108-11. PubMed ID: 12388862
    [No Abstract]   [Full Text] [Related]  

  • 16. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-sector review of drivers and available 3Rs approaches for acute systemic toxicity testing.
    Seidle T; Robinson S; Holmes T; Creton S; Prieto P; Scheel J; Chlebus M
    Toxicol Sci; 2010 Aug; 116(2):382-96. PubMed ID: 20484382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerating the Pace of Chemical Risk Assessment.
    Kavlock RJ; Bahadori T; Barton-Maclaren TS; Gwinn MR; Rasenberg M; Thomas RS
    Chem Res Toxicol; 2018 May; 31(5):287-290. PubMed ID: 29600706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA).
    Tollefsen KE; Scholz S; Cronin MT; Edwards SW; de Knecht J; Crofton K; Garcia-Reyero N; Hartung T; Worth A; Patlewicz G
    Regul Toxicol Pharmacol; 2014 Dec; 70(3):629-40. PubMed ID: 25261300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mind the gaps: Prioritizing activities to meet regulatory needs for acute systemic lethality.
    Sullivan K; Allen DG; Clippinger AJ; Wilson DM; Edwards SW; Glover K; Mansouri K; Settivari R; Wijeyesakere SJ; Casey W
    ALTEX; 2021; 38(2):327-335. PubMed ID: 33511999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.